Brain Case was founded by the brain science research team of the Chinese Academy of Sciences. In the past ten years, Brain Case has taken the task of revealing the "brain black box" and focused on the research of tool virus vector and application strategies, including Neurophilic virus vector (RV, PRV, HSV, VSV, CAV, etc.), Adeno-associated virus (rAAV) vector for gene therapy and its preparation system, oncolytic virus, etc. Brain Case not only has more than 20 independent intellectual property rights, but also has built a full process GMP production and experimental platform, which is in a leading position in the industry.

Brain Case is headquartered in Guangming District, Shenzhen, with a R&D and technical teams of more than 40 people. Brain Case will change from basic research of neural circuit to preclinical research, and carry out experimental outsourcing services for clinical and pharmaceutical companies while serving basic research of life sciences.